tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:6160 Stock Latest News

BeOne Medicines Secures Regulatory Waivers for Enhanced Flexibility
Company AnnouncementsBeOne Medicines Secures Regulatory Waivers for Enhanced Flexibility
2d ago
6160
BeOne Medicines Ltd. to Announce Q3 2025 Financial Results
PremiumCompany Announcements
BeOne Medicines Ltd. to Announce Q3 2025 Financial Results
11d ago
6160
BeOne Medicines price target raised to $383 from $350 at Morgan Stanley
PremiumThe Fly
BeOne Medicines price target raised to $383 from $350 at Morgan Stanley
13d ago
ONC
BeOne Medicines to present data from Phase 3 trials RATIONALE-307 and 312
PremiumThe Fly
BeOne Medicines to present data from Phase 3 trials RATIONALE-307 and 312
13d ago
ONC
BeOne Medicines Ltd. Announces Name and Stock Short Name Change
PremiumCompany Announcements
BeOne Medicines Ltd. Announces Name and Stock Short Name Change
16d ago
6160
BeOne Medicines’ sonrotoclax granted Breakthrough Therapy Designation by FDA
PremiumThe FlyBeOne Medicines’ sonrotoclax granted Breakthrough Therapy Designation by FDA
20d ago
ONC
BeOne Medicines Ltd. Announces Grant of RSUs and PSUs
Premium
Company Announcements
BeOne Medicines Ltd. Announces Grant of RSUs and PSUs
25d ago
6160
BeOne Medicines Resolves Patent Dispute with Pharmacyclics
Premium
Company Announcements
BeOne Medicines Resolves Patent Dispute with Pharmacyclics
1M ago
6160
BeOne Medicines initiated with an Overweight at Barclays
PremiumThe Fly
BeOne Medicines initiated with an Overweight at Barclays
2M ago
ONC
BeOne Medicines Completes Employee Share Purchase Plan
PremiumCompany Announcements
BeOne Medicines Completes Employee Share Purchase Plan
2M ago
6160
BeiGene Ltd’s Earnings Call Highlights Strong Growth
PremiumCompany Announcements
BeiGene Ltd’s Earnings Call Highlights Strong Growth
2M ago
6160
BeOne Medicines Ltd. Launches New Employee Share Purchase Plan Offering
PremiumCompany Announcements
BeOne Medicines Ltd. Launches New Employee Share Purchase Plan Offering
2M ago
6160
BeOne Medicines Ltd. Announces Grant of Restricted Share Units to Employees
PremiumCompany AnnouncementsBeOne Medicines Ltd. Announces Grant of Restricted Share Units to Employees
2M ago
6160
Optimistic Buy Rating for BeOne Medicines Driven by Promising Sonrotoclax Trial Results and Market Potential
Premium
Ratings
Optimistic Buy Rating for BeOne Medicines Driven by Promising Sonrotoclax Trial Results and Market Potential
2M ago
ONC
BeOne Medicines Announces Promising Results for Sonrotoclax in Mantle Cell Lymphoma
Premium
Company Announcements
BeOne Medicines Announces Promising Results for Sonrotoclax in Mantle Cell Lymphoma
2M ago
6160
BeOne Medicines reports ‘positive’ results from Phase 1/2 study of sonrotoclax
PremiumThe Fly
BeOne Medicines reports ‘positive’ results from Phase 1/2 study of sonrotoclax
2M ago
ONC
BeOne Medicines Ltd. Reports Robust Revenue Growth and Returns to Profitability in H1 2025
PremiumCompany Announcements
BeOne Medicines Ltd. Reports Robust Revenue Growth and Returns to Profitability in H1 2025
2M ago
6160
BeOne Medicines announces EC approved Tevimbra to treat NSCLC
PremiumThe Fly
BeOne Medicines announces EC approved Tevimbra to treat NSCLC
2M ago
ONC
Royalty Pharma confirms acquisition of royalty interest in Amgen’s Imdelltra
PremiumThe Fly
Royalty Pharma confirms acquisition of royalty interest in Amgen’s Imdelltra
2M ago
ONC
AMGN
BeOne Medicines Secures $885 Million Royalty Deal with Royalty Pharma
PremiumCompany AnnouncementsBeOne Medicines Secures $885 Million Royalty Deal with Royalty Pharma
2M ago
6160
BeOne Medicines to sell royalty rights of Imdelltra to Royalty Pharma for $950M
Premium
The Fly
BeOne Medicines to sell royalty rights of Imdelltra to Royalty Pharma for $950M
2M ago
ONC
AMGN
BeOne Medicines’ Brukinsa tablet formulation approved by European Commission
Premium
The Fly
BeOne Medicines’ Brukinsa tablet formulation approved by European Commission
2M ago
ONC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >